Eli Lilly and Company (SWX:LLY)
Switzerland · Delayed Price · Currency is CHF 595.00
+5.00 (0.85%)
At close: Sep 4, 2025
Eli Lilly and Company Market Cap
Eli Lilly and Company has a market cap or net worth of 537.70 billion as of September 5, 2025. Its market cap has decreased by -25.02% in one year.
Market Cap
537.70B
Enterprise Value
566.80B
Revenue
42.36B
Ranking
n/a
PE Ratio
48.99
Stock Price
595.00
Market Cap Chart
Since July 9, 1970, Eli Lilly and Company's market cap has increased from 3.09B to 537.70B, an increase of 17,297.94%. That is a compound annual growth rate of 9.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2025 | 537.70B | -14.64% |
| Dec 31, 2024 | 629.92B | 42.70% |
| Dec 29, 2023 | 441.43B | 37.33% |
| Dec 30, 2022 | 321.43B | 40.80% |
| Dec 31, 2021 | 228.28B | 68.57% |
| Dec 31, 2020 | 135.43B | 10.81% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 237.12B |
| Novartis AG | 199.55B |
| Lonza Group AG | 40.61B |
| Galderma Group AG | 33.64B |
| Alcon | 31.07B |
| Sandoz Group AG | 21.16B |
| Straumann Holding AG | 15.08B |
| Sonova Holding AG | 14.16B |